The 13th World Congress on Controversies in Obstetrics, Gynecology & Infertility (COGI) Held jointly with The German Society of Obstetrics & Gynecology
Maritim Hotel,Berlin, Germany, November 4-7, 2010
Timetable
THURSDAY, NOVEMBER 4, 2010
16:00-17:30
Modern Menopause Management - Why is Progestin Choice so Important? Sponsored session by Bayer Schering Pharma AG
17:30-19:00
Opening Session
19:00-20:30
Welcome Reception
FRIDAY, NOVEMBER 5, 2010
Hall A
Hall B
Hall C
Hall D
08:30-10:00
50 Years of The Pill
Sponsored session by Bayer Schering Pharma AG
The Challenges of Perinatal Viability
The End of Preimplantation Genetic Screening (PGS) or Only the Beginning?
Operative Procedures: Tricks of the Trade
10:00-10:20
Coffee Break
10:20-11:50
Controversies in Heavy Menstrual Bleeding Sponsored session by Bayer Schering Pharma AG
Early Diagnosis of Premature Rupture of Fetal Membranes (PROM)
Sponsored by an unrestricted grant from AmniSure® International
SPRM's - New Player in the Treatment of Uterine Fibroids!
Sponsored by an unrestricted grant fromPregLem SA
Future and Novel Treatments for Epithelial Ovarian Cancers
11:50-12:10
Poster Reviewing
12:10-13:40
Innovation in Endometriosis Treatment Sponsored session by Bayer Schering Pharma AG
Prematurity Sponsored by an unrestricted grant from Hologic (UK) Limited
13:40-14:30
Lunch Break
14:30-16:00
Androgen Restored Contraception Sponsored by an unrestricted grant by Pantarhei Bioscience
Uterine Contractility
Assessment and Treatment of Ovarian Reserve
Epithelial Ovarian Cancer: Current Standards of Care
16:00-16:30
Coffee Break
16:30-18:00
What is in the Pipeline for Hypoactive Sexual Desire Disorders (HSDD)?
Progesterone: From Luteal Support to Abortions
Hot controversial topics in ART Round Table Discussion
Breast Cancer
SATURDAY, NOVEMBER 6, 2010
Hall A
Hall B
Hall C
Hall D
08:30-10:00
Endoscopy
Sponsored by an unrestricted grant from Storz GmbH & Co. KG
Controversies in Prenatal Diagnosis and Therapy
In Vitro Maturation (IVM)
Breast Cancer From Bench to Bedside: Translational research in Oncology
10:00-10:20
Coffee Break
10:20-11:50
Selective Estrogen Receptor Modulators (SERM's): Present and Future Sponsored by a restricted grant from DAIICHI SANKYO EUROPE GmbH
Avoiding Invasive Prenatal Diagnosis
Laboratory Techniques
Cervical Cancer and Human Papilloma Virus (HPV)
11:50-12:10
Poster Reviewing
12:10-13:40
Epithelial Ovarian Cancer: Can Survival be Improved through Early Detection and Triage? Sponsored by an unrestricted grant from Fujirebio Diagnostics Inc.
Prediction of Hypertensive Disorders in Pregnancy
Mild Stimulation for IVF Organized by ISMAAR
Endometrial Cancer
13:40-14:30
Lunch Break
14:30-16:00
Epithelial Ovarian Cancer (ii): The Place of Biomarker and Imaging in the Management of Ovarian Cancer Sponsored by an unrestricted grant from Abbott Diagnostics Inc.
3-D and 4-D Ultrasound in Modern Perinatal Medicine and Neurobehavioral Assessment
Endometriosis during Reproductive Years
Postmenopausal Osteoporosis
16:00-16:30
Coffee Break
16:30-18:00
Deep Endometriosis
Evidence-Based Medicine (EBM): "Holy Grail" or More Doubts?
Differences in Regulations of ART
Hormone Replacement Therapy (HRT), Quo Vadis?
SUNDAY, NOVEMBER 7, 2010
Hall A
Hall B
Hall C
Hall D
08:30-10:00
Ultrasound (US) Screening for Anomalies
Polycystic Ovarian Syndrome (PCOS)
10:00-10:30
Coffee Break
10:30-12:30
Controversies over Endless Cesarean Delivery and Multiple Pregnancies
New Cryotechnologies for Gametes, Ovarian Tissue and Stem Cells